Trials / Completed
CompletedNCT04498923
Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants
Duration of Blockade of Peripheral Nerves With Low Concentrated Bupivacaine Solution Depending of the Adjuvants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Lviv National Medical University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The main aim of the investigator's study is to propose combination of local anesthetics and adjuvants that provides both adequate anesthesia during surgery and prolonged post-operative analgesia.
Detailed description
Peripheral nerve plexuses blocks are performing as a component of analgesia in patients undergoing orthopedic surgery on the upper or lower extremities. Patients are divided into two groups depending on the adjuvant to the local anesthetic: 1st group - patients whose blockade is performed with a solution of bupivacaine 0.375% together with dexamethasone 0.02%; Group 2 - patients whose blockade is performed with a solution of bupivacaine 0.375% together with dexamethasone 0.02% and epinephrine 0.00018%. The duration of the blockade is estimated by puncturing the skin with a needle. The intensity of pain is assessed at 6, 12, 24 and 36 hours after blockade using Visual analog scale (VAS). The amount of narcotic anesthetic used in the postoperative period is also recorded. In addition, patients underwent electromyography of the innervation area of the blocked nerve before the surgery and 24 and 36 hours after surgery.
Conditions
- Postoperative Pain
- Peripheral Neuropathy
- Fractures of the Upper Limb
- Fracture of the Lower Limb (Except Hip), Initial Encounter
- Intraoperative Hypotension
- Intraoperative Hypertension
- Pain Syndrome
- Anesthesia
- Anesthesia, Local
- Local Anesthetic Systemic Toxicity
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine, dexamethasone, epinephrine | Bupivacaine 75 mg, dexamethasone 4 mg, epinephrine 0,18 mg |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2022-04-05
- Completion
- 2022-04-05
- First posted
- 2020-08-05
- Last updated
- 2022-04-13
Locations
1 site across 1 country: Ukraine
Source: ClinicalTrials.gov record NCT04498923. Inclusion in this directory is not an endorsement.